Kidney Health Coaching for Advanced Kidney Disease
This study, called "Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease," is testing if Kidney Health Coaching can help people with advanced kidney disease. You might be able to join if you identify as African American or Black, are 18 or older, and have specific kidney function test results (eGFR less than 29) or a high risk of kidney failure. The study aims to see if this coaching can delay the need for kidney replacement therapy (like dialysis) or a central venous catheter, and also delay death. The coaching involves support from a Kidney Health Coach, who has personal experience with kidney disease, through phone calls and in-person meetings for six months. The study compares this coaching to usual care, which might include support from care management at the hospital.
- Study design
- This is an interventional study with a planned enrollment of 600 participants. It uses a randomized controlled trial design, meaning participants will be randomly assigned to either receive Kidney Health Coaching or usual care.
- What's involved
- If you participate, you would receive ongoing telephone support at least twice a month for six months, and the Kidney Health Coach would meet you at all in-person clinic appointments. You would also complete a baseline assessment via telephone interview.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed throughout study participation up to 12 months to measure the time to kidney replacement therapy and death.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
At a glance
Conditions
NCT06693661
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Emory Healthcare System
Atlanta, Georgiano site contact published
Recruiting
Emory University Hospital Midtown
Atlanta, Georgiano site contact published
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Kimberly R Jacob Arriola, PhD, MPH · PRINCIPAL_INVESTIGATOR · Emory University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Time-to-Kidney Replacement Therapy w/Central Venous CatheterThroughout study participation up to 12 months
Composite measure of time to transition to Kidney Replacement Therapy (KRT) using a central venous catheter (CVC) over the course of the study period
- Time-to-deathThroughout study participation up to 12 months
Composite measure of time to death over the course of the study period. A record of death in the electronic medical record (EMR), and the date of death will be recorded. If the data is not available in EMR, national death statistics will be checked, and the patient's family will be asked.